Hydrocodone Bitartrate And Acetaminophen
Product Images NDC 76519-1081

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Hydrocodone Bitartrate And Acetaminophen (NDC 76519-1081). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 1079 (76519 1079 Ppac Label)

This is a description of a Hydrocodone/Acetaminophen prescription medication in tablet form. It is similar to Vicodin ES and comes in a bottle with a Lot# ABOOCD and an expiration date. The manufacturer is Mig. BOGA PHARM and the dosage is 7.5/300mg per tablet. The product has a caution indicating that federal law prohibits its transfer to anyone other than the person it was prescribed for, and that it should be kept out of reach of children. The recommended use is as directed by a physician. There are multiple NDC and manufacturer codes, as well as the name of a possible packager.*

FDA Label Image

Label 1081 (76519 1081 Ppac Label)

This is a description of a medication with the brand name HYDROGOD. It comes in tablet form with a strength of 5mg/300mg. The medication should be used as directed by a physician. The NDC number is 76518-1081-XX and the lot number is ABOOCD. The manufacturer is BOGA PHARM. The medication contains Hydrocodone Bitartrate and Acetaminophen. It is important to keep it out of reach of children and store in a cool place. The packaging includes a caution for legal reasons. The rereading of the company name mentions an H.J. HARKINS Go. Inc. Grover Beach.*

FDA Label Image

Image 1 (Image 1)

FDA Label Image

Image (Image)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.